HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$890M |
| 2 |
Apple
AAPL
|
+$842M |
| 3 |
Microsoft
MSFT
|
+$360M |
| 4 |
Equitable Holdings
EQH
|
+$212M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$129M |
| 2 |
Citigroup
C
|
+$103M |
| 3 |
Elevance Health
ELV
|
+$93.4M |
| 4 |
Arch Capital
ACGL
|
+$90.7M |
| 5 |
Crown Holdings
CCK
|
+$90M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Financials | 12.74% |
| 3 | Healthcare | 11.23% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
CALL
Li Auto
LI
$13.4B
| $131K | ﹤0.01% |
+3,500
| New | +$126K |
|
2552
Entravision Communication
EVC
$1.03B
| $131K | ﹤0.01% |
31,089
+5,996
| +24% | +$23.7K |
|
2553
Marqeta
MQ
$1.83B
| $129K | ﹤0.01% |
4,624
+937
| +25% | +$22.4K |
|
|
INFN
2554
DELISTED
Infinera Corporation Common Stock
INFN
| $129K | ﹤0.01% |
27,028
+3,686
| +16% | +$14.5K |
|
2555
Information Services Group
III
$199M
| $129K | ﹤0.01% |
26,777
| – | – |
|
2556
Fortuna Silver Mines
FSM
$2.55B
| $128K | ﹤0.01% |
33,051
| – | – |
|
2557
Treace Medical Concepts
TMCI
$280M
| $128K | ﹤0.01% |
+10,127
| New | +$102K |
|
2558
Ooma
OOMA
$598M
| $128K | ﹤0.01% |
11,938
-10,004
| -46% | -$114K |
|
|
CTEV
2559
Claritev Corp
CTEV
$387M
| $127K | ﹤0.01% |
2,148
+873
| +68% | +$53K |
|
2560
BioCryst Pharmaceuticals
BCRX
$2.28B
| $127K | ﹤0.01% |
21,035
+2,160
| +11% | +$12.5K |
|
2561
MaxCyte
MXCT
$112M
| $124K | ﹤0.01% |
27,535
-5,046
| -15% | -$19.6K |
|
2562
Kodiak Sciences
KOD
$2.6B
| $124K | ﹤0.01% |
40,821
+26
| +0.1% | +$58 |
|
|
SAND
2563
DELISTED
Sandstorm Gold
SAND
| $124K | ﹤0.01% |
24,383
-32,713
| -57% | -$156K |
|
2564
Vanda Pharmaceuticals
VNDA
$307M
| $123K | ﹤0.01% |
+29,207
| New | +$118K |
|
2565
Lifestance Health
LFST
$4B
| $123K | ﹤0.01% |
+15,600
| New | +$101K |
|
2566
Zymeworks
ZYME
$1.61B
| $123K | ﹤0.01% |
11,749
| – | – |
|
2567
Voyager Therapeutics
VYGR
$183M
| $122K | ﹤0.01% |
+14,322
| New | +$104K |
|
|
BCOV
2568
DELISTED
Brightcove, Inc.
BCOV
| $120K | ﹤0.01% |
46,964
+15,753
| +50% | +$42.3K |
|
2569
Rackspace Technology
RXT
$1.05B
| $120K | ﹤0.01% |
60,208
+1,397
| +2% | +$2.11K |
|
2570
PUT
Keurig Dr Pepper
KDP
$42.3B
| $120K | ﹤0.01% |
+3,600
| New | +$112K |
|
2571
KVH Industries
KVHI
$181M
| $119K | ﹤0.01% |
+22,842
| New | +$112K |
|
|
NB
2572
NioCorp Developments
NB
$619M
| $119K | ﹤0.01% |
37,458
+11,002
| +42% | +$39.8K |
|
|
TPC
2573
Tutor Perini Cor
TPC
$4.41B
| $118K | ﹤0.01% |
12,936
+1,314
| +11% | +$10.5K |
|
2574
PMV Pharmaceuticals
PMVP
$59.2M
| $118K | ﹤0.01% |
39,079
+8,400
| +27% | +$22.2K |
|
2575
Design Therapeutics
DSGN
$761M
| $118K | ﹤0.01% |
45,055
+8,565
| +23% | +$19.6K |
|
Similar funds
HSBC Holdings's Q4 2023 Portfolio in Review
As of Q4 2023, HSBC Holdings held 2,994 positions worth $115B, up 19% from $96.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
HSBC Holdings deployed $6.98B of net new capital in Q4 2023, opening 295 new positions and adding to 1,230 existing holdings. Its largest new stake was GSK: 2,495,096 shares worth $92.3M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Citigroup, an estimated $103M trimmed.
- HSBC Holdings's largest Q4 2023 buy was GSK: 2,495,096 shares worth $92.3M.
- HSBC Holdings added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $890M increase.
- HSBC Holdings's biggest Q4 2023 reduction was Citigroup, cutting an estimated $103M.
- HSBC Holdings fully exited Activision Blizzard in Q4 2023, selling an estimated $129M.
- HSBC Holdings's ten largest holdings make up 26% of its $115B portfolio in Q4 2023.
- HSBC Holdings opened 295 new positions and closed 291 in Q4 2023.
- HSBC Holdings's portfolio value rose 19% quarter-over-quarter to $115B.
Based on HSBC Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.